Detalhe da pesquisa
1.
Crosstalk between tumor acidosis, p53 and extracellular matrix regulates pancreatic cancer aggressiveness.
Int J Cancer;
152(6): 1210-1225, 2023 03 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36408933
2.
Optical and Optoacoustic Imaging.
Recent Results Cancer Res;
216: 439-492, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32594395
3.
Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.
Int J Cancer;
142(10): 2118-2129, 2018 05 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29277891
4.
Influence of Label and Charge Density on the Association of the Therapeutic Monoclonal Antibodies Trastuzumab and Cetuximab Conjugated to Anionic Fluorophores.
Chembiochem;
18(1): 101-110, 2017 Jan 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27790811
5.
Preclinical evaluation of near-infrared (NIR) fluorescently labeled cetuximab as a potential tool for fluorescence-guided surgery.
Int J Cancer;
139(10): 2277-89, 2016 11 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27428782
6.
Targeting of the P2X7 receptor in pancreatic cancer and stellate cells.
Int J Cancer;
139(11): 2540-52, 2016 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27513892
7.
In vivo imaging of tumour xenografts with an antibody targeting the potassium channel Kv10.1.
Eur Biophys J;
45(7): 721-733, 2016 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27444284
8.
Multifunctional phosphate-based inorganic-organic hybrid nanoparticles.
J Am Chem Soc;
137(23): 7329-36, 2015 Jun 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26018463
9.
Functionalized synchrotron in-line phase-contrast computed tomography: a novel approach for simultaneous quantification of structural alterations and localization of barium-labelled alveolar macrophages within mouse lung samples.
J Synchrotron Radiat;
22(1): 143-55, 2015 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25537601
10.
Cocktail of lipophilic and hydrophilic chemotherapeutics in high-load core@shell nanocarriers to treat pancreatic tumours.
Nanoscale Adv;
6(3): 973-984, 2024 Jan 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38298597
11.
Knockdown of prolyl-4-hydroxylase domain 2 inhibits tumor growth of human breast cancer MDA-MB-231 cells by affecting TGF-ß1 processing.
Int J Cancer;
132(12): 2787-98, 2013 Jun 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23225569
12.
Theranostic inorganic-organic hybrid nanoparticles with a cocktail of chemotherapeutic and cytostatic drugs.
J Mater Chem B;
11(16): 3635-3649, 2023 04 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37017673
13.
High-Load Gemcitabine Inorganic-Organic Hybrid Nanoparticles as an Image-Guided Tumor-Selective Drug-Delivery System to Treat Pancreatic Cancer.
Adv Mater;
35(46): e2305151, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37587542
14.
Monitoring nanoparticle dissolution via fluorescence-colour shift.
Nanoscale;
14(43): 16249-16255, 2022 Nov 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36285794
15.
pH-Dependent fluorescence of [La(OH)2]+[ARS]- hybrid nanoparticles for intracellular pH-sensing.
Chem Commun (Camb);
58(67): 9417-9420, 2022 Aug 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35916280
16.
Spectroscopically well-characterized RGD optical probe as a prerequisite for lifetime-gated tumor imaging.
Mol Imaging;
10(6): 469-80, 2011 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22201538
17.
Targeted luminescent near-infrared polymer-nanoprobes for in vivo imaging of tumor hypoxia.
Anal Chem;
83(23): 9039-46, 2011 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22007722
18.
Optical imaging in vivo with a focus on paediatric disease: technical progress, current preclinical and clinical applications and future perspectives.
Pediatr Radiol;
41(2): 161-75, 2011 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21221568
19.
Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments.
Cell Death Dis;
12(12): 1118, 2021 11 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34845197
20.
Time-domain in vivo near infrared fluorescence imaging for evaluation of matriptase as a potential target for the development of novel, inhibitor-based tumor therapies.
Int J Cancer;
127(8): 1958-74, 2010 Oct 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20473895